Category Archives: Specialty Drug

Capital Rx Expands Transparency Model to Specialty and Mail Prescriptions

Capital Rx works to increase cost transparency and consistency for its clients by using the government-maintained National Average Drug Acquisition Cost database, which aims to provide accurate, upfront costs of drugs across pharmacies to health plans

Onco360’s Pharmacy Network the Choice for New Oncology Treatments

Onco360, a subsidiary of PharMerica, is one of the nation’s leading providers of Oncology Pharmacy services

AmerisourceBergen selected by Deciphera to support QINLOCK (ripretinib)

AmerisourceBergen’s commercialization support services offer an integrated approach to drug launches

Lundbeck’s Vyepti Distributed by Only Two Specialty Pharmacies

Lundbeck has named AllianceRx and Orsini as the only two specialty pharmacies to distribute Vyepti

Immunomedics Chooses Biologics as Sole Specialty Pharmacy Distributor

Trodelvy is the first anti-Trop-2 ADC recently approved by the FDA for the treatment of adult patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease

Programs Covering the Cost of Gene Therapies Increase

Cell and gene therapies are revolutionizing the field of medicine by offering life-changing benefits to people with rare diseases and cancers

Insurers Using Site of Care Optimization to Reduce Specialty Drug Costs

Manufacturers are increasingly being affected by the commercial insurance market’s shift of medical coverage policies to lower-cost alternate sites

Jelmyto Poised for Successful Commercial Launch

UroGen has been preparing for the commercialization of Jelmyto by increasing customer awareness and discussing the high unmet need in low-grade UTUC